Dallas, TX (PRWEB) August 23, 2012
Actos (pioglitazone) is a drug that is prescribed to those who suffered from diabetes, but concerns have risen that the drug could possibly be connected to patients developing bladder cancer, which has prompted the drug makers to include this on the product’s label. Although the drug has not been recalled by the FDA in the United States, it has increased the warning of injury in its marketing. Jackson Allen & Williams, PLLC is an injury firm serving the residents of Dallas, Texas and the surrounding areas. They recently launched a television campaign in order to spread the news about Actos and the damage that it could potentially cause patients.
The television campaign is going to focus on targeting those who took Actos as well as those considering using the drug to treat their diabetes. Individuals who display certain side effects may be able to file a claim against Takeda Pharmaceuticals, the manufacturer of this drug. Actos was released onto the market back in 1999, but a safety announcement was not issued until June 15, 2011. According to this announcement, patients were warned of the increased risk of bladder cancer and were also warned to immediately report any unusual side effects to their health care providers. The FDA is conducting an ongoing safety review of the drug.
This Actos TV campaign will also include helpful information about the drug, some of the common side effects and what consumers can do if they find that they are among those suffering complications because of the drug. Jackson Allen & Williams is currently taking on cases of alleged Actos injury, which is a key message that they want to spread through their TV campaign. If you or a loved one has been diagnosed with bladder cancer or another serious illness that may be in conjunction with your use of pioglitazone, then you can inquire about taking legal action. The firm encourages concerned patients to call them for more information.
The FDA has recently approved the sale of the generic version of Actos on the market, simply called “pioglitazone hydrochloride” in an FDA news release from August 17th of this year. Since this drug is nearly identical to Actos without the label, patients may be unaware of the possibility of serious health effects. Those who develop urinary bladder cancer will have to undergo serious treatment as a result. Jackson Allen & Williams also wants to spread the news about this generic version of Actos, and hopes to better inform patients of the drug’s properties.
This may leave patients wondering what they can do to procure this kind of treatment. Although a definite link between the drug and bladder cancer has not yet been proven, with the help of Jackson Allen & Williams, those with bladder cancer and other serious side effects have a chance to fight for their rights and get compensation by way of a verdict or settlement in order to cover the cost of treatment. There are currently lawsuits pending across the nation regarding Actos and its alleged connection to causing serious diseases. With the launch of this campaign, the firm hopes to spread the word about the dangers of this drug and provide legal help to those seeking it.
Jackson Allen & Williams, LLP is Board Certified® by the Texas Board of Legal Specialization. This means that they are among few firms in Texas that are considered specialists in the field of personal injury. The firm is passionate about defending the rights of victims, so talk to them if you or a loved one has been injured by Actos or a generic version of pioglitazone. Visit their website for more information at http://www.AccidentInjuryFirm.com.